| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: Q4Q988
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003676 | nucleic acid binding | 3 | 8 |
| GO:0003723 | RNA binding | 4 | 8 |
| GO:0005488 | binding | 1 | 8 |
| GO:0097159 | organic cyclic compound binding | 2 | 8 |
| GO:1901363 | heterocyclic compound binding | 2 | 8 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 243 | 247 | PF00656 | 0.600 |
| CLV_C14_Caspase3-7 | 312 | 316 | PF00656 | 0.689 |
| CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.681 |
| CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.681 |
| CLV_PCSK_SKI1_1 | 133 | 137 | PF00082 | 0.719 |
| CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.307 |
| DEG_SCF_FBW7_2 | 286 | 293 | PF00400 | 0.805 |
| DOC_CKS1_1 | 287 | 292 | PF01111 | 0.732 |
| DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.532 |
| DOC_USP7_MATH_1 | 275 | 279 | PF00917 | 0.754 |
| DOC_USP7_MATH_1 | 296 | 300 | PF00917 | 0.741 |
| DOC_USP7_MATH_1 | 311 | 315 | PF00917 | 0.611 |
| DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.423 |
| DOC_USP7_MATH_1 | 58 | 62 | PF00917 | 0.485 |
| DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.499 |
| DOC_WW_Pin1_4 | 189 | 194 | PF00397 | 0.702 |
| DOC_WW_Pin1_4 | 286 | 291 | PF00397 | 0.731 |
| DOC_WW_Pin1_4 | 3 | 8 | PF00397 | 0.574 |
| LIG_14-3-3_CanoR_1 | 30 | 38 | PF00244 | 0.454 |
| LIG_BIR_III_2 | 262 | 266 | PF00653 | 0.560 |
| LIG_BIR_III_4 | 257 | 261 | PF00653 | 0.546 |
| LIG_BRCT_BRCA1_1 | 131 | 135 | PF00533 | 0.714 |
| LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.499 |
| LIG_FHA_1 | 100 | 106 | PF00498 | 0.524 |
| LIG_FHA_1 | 171 | 177 | PF00498 | 0.591 |
| LIG_FHA_1 | 186 | 192 | PF00498 | 0.604 |
| LIG_FHA_1 | 19 | 25 | PF00498 | 0.548 |
| LIG_FHA_2 | 163 | 169 | PF00498 | 0.573 |
| LIG_FHA_2 | 301 | 307 | PF00498 | 0.710 |
| LIG_FHA_2 | 4 | 10 | PF00498 | 0.721 |
| LIG_LIR_Apic_2 | 79 | 83 | PF02991 | 0.517 |
| LIG_LIR_Gen_1 | 203 | 209 | PF02991 | 0.537 |
| LIG_LIR_Nem_3 | 246 | 252 | PF02991 | 0.594 |
| LIG_LIR_Nem_3 | 4 | 8 | PF02991 | 0.603 |
| LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.520 |
| LIG_LIR_Nem_3 | 60 | 65 | PF02991 | 0.513 |
| LIG_PDZ_Class_3 | 325 | 330 | PF00595 | 0.767 |
| LIG_PROFILIN_1 | 264 | 270 | PF00235 | 0.553 |
| LIG_SH2_CRK | 80 | 84 | PF00017 | 0.517 |
| LIG_SH2_STAP1 | 205 | 209 | PF00017 | 0.598 |
| LIG_SH2_STAT3 | 32 | 35 | PF00017 | 0.460 |
| LIG_SH2_STAT5 | 252 | 255 | PF00017 | 0.594 |
| LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.460 |
| LIG_SH2_STAT5 | 91 | 94 | PF00017 | 0.553 |
| LIG_SH3_1 | 261 | 267 | PF00018 | 0.723 |
| LIG_SH3_3 | 261 | 267 | PF00018 | 0.765 |
| LIG_SH3_3 | 52 | 58 | PF00018 | 0.555 |
| LIG_SUMO_SIM_par_1 | 112 | 118 | PF11976 | 0.642 |
| LIG_WRC_WIRS_1 | 2 | 7 | PF05994 | 0.653 |
| MOD_CK1_1 | 118 | 124 | PF00069 | 0.656 |
| MOD_CK1_1 | 160 | 166 | PF00069 | 0.696 |
| MOD_CK1_1 | 171 | 177 | PF00069 | 0.681 |
| MOD_CK1_1 | 278 | 284 | PF00069 | 0.729 |
| MOD_CK2_1 | 162 | 168 | PF00069 | 0.699 |
| MOD_CK2_1 | 300 | 306 | PF00069 | 0.721 |
| MOD_CK2_1 | 48 | 54 | PF00069 | 0.438 |
| MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.685 |
| MOD_GlcNHglycan | 121 | 124 | PF01048 | 0.642 |
| MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.714 |
| MOD_GlcNHglycan | 193 | 196 | PF01048 | 0.750 |
| MOD_GlcNHglycan | 272 | 275 | PF01048 | 0.704 |
| MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.562 |
| MOD_GlcNHglycan | 67 | 71 | PF01048 | 0.314 |
| MOD_GlcNHglycan | 74 | 77 | PF01048 | 0.321 |
| MOD_GSK3_1 | 115 | 122 | PF00069 | 0.650 |
| MOD_GSK3_1 | 157 | 164 | PF00069 | 0.673 |
| MOD_GSK3_1 | 185 | 192 | PF00069 | 0.714 |
| MOD_GSK3_1 | 296 | 303 | PF00069 | 0.720 |
| MOD_GSK3_1 | 44 | 51 | PF00069 | 0.544 |
| MOD_GSK3_1 | 72 | 79 | PF00069 | 0.499 |
| MOD_N-GLC_1 | 171 | 176 | PF02516 | 0.728 |
| MOD_NEK2_1 | 1 | 6 | PF00069 | 0.666 |
| MOD_NEK2_1 | 115 | 120 | PF00069 | 0.624 |
| MOD_NEK2_1 | 136 | 141 | PF00069 | 0.698 |
| MOD_NEK2_1 | 72 | 77 | PF00069 | 0.516 |
| MOD_PIKK_1 | 136 | 142 | PF00454 | 0.779 |
| MOD_PIKK_1 | 31 | 37 | PF00454 | 0.450 |
| MOD_PKA_2 | 136 | 142 | PF00069 | 0.693 |
| MOD_PKA_2 | 157 | 163 | PF00069 | 0.723 |
| MOD_Plk_1 | 84 | 90 | PF00069 | 0.542 |
| MOD_Plk_4 | 300 | 306 | PF00069 | 0.554 |
| MOD_ProDKin_1 | 189 | 195 | PF00069 | 0.702 |
| MOD_ProDKin_1 | 286 | 292 | PF00069 | 0.733 |
| MOD_ProDKin_1 | 3 | 9 | PF00069 | 0.576 |
| MOD_SUMO_for_1 | 49 | 52 | PF00179 | 0.555 |
| MOD_SUMO_rev_2 | 206 | 214 | PF00179 | 0.675 |
| TRG_ENDOCYTIC_2 | 205 | 208 | PF00928 | 0.555 |
| TRG_ENDOCYTIC_2 | 56 | 59 | PF00928 | 0.527 |
| TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.505 |
| TRG_ER_diArg_1 | 220 | 222 | PF00400 | 0.658 |
| TRG_Pf-PMV_PEXEL_1 | 251 | 255 | PF00026 | 0.636 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P6I9 | Leptomonas seymouri | 57% | 99% |
| A0A3Q8ICS1 | Leishmania donovani | 92% | 100% |
| A0A422NSU1 | Trypanosoma rangeli | 41% | 100% |
| A4HEW2 | Leishmania braziliensis | 82% | 90% |
| A4I235 | Leishmania infantum | 92% | 100% |
| E9AY85 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |